Details for 2021772839

Up to date per 03.04.2026

Actions

Title / Product Name

BEWERTUNGSVERFAHREN FÜR EINE ANTI-HER2-ANTIKÖRPER-WIRKSTOFF-KONJUGATTHERAPIE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021772839

EP Publication Number

4211598

E-Number

1876018

Language

PCT Number

IB21058273

Publication Date

19.07.2023 A

07.01.2026 B1

Registration Date

07.01.2026

AT Publication Date

15.01.2026

Application Date

11.09.2021

Registration Number

Priorities

12.09.2020

202063077604 P

IPC

G06F 18/2413 20230101AFI20250929BHEP

Maximum Duration of Protection

11.09.2041

Owner

AstraZeneca UK Limited1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AAGB

Daiichi Sankyo Company, Limited3-5-1 Nihonbashi-honcho Chuo-ku Tokyo 103-8426JP

Representative

No representatives present

Inventor

SCHMIDT, Guenter 80999 MunichDE

BRIEU, Nicolas 81543 MunichDE

SPITZMUELLER, Andreas 83052 BruckmuehlDE

KAPIL, Ansh 80339 MunichDE

Information about Fees